171 related articles for article (PubMed ID: 25778989)
1. C4d immunostaining is an independent predictor of cardiac allograft vasculopathy and death in heart transplant recipients.
Luk A; Alba AC; Butany J; Tinckam K; Delgado D; Ross HJ
Transpl Int; 2015 Jul; 28(7):857-63. PubMed ID: 25778989
[TBL] [Abstract][Full Text] [Related]
2. Capillary deposition of the complement fragment C4d in cardiac allograft biopsies is associated with allograft vasculopathy.
Poelzl G; Ullrich R; Huber A; Ulmer H; Antretter H; Hoefer D; Mairinger T; Laufer G; Pachinger O; Schwarzacher S
Transpl Int; 2005 Mar; 18(3):313-7. PubMed ID: 15730492
[TBL] [Abstract][Full Text] [Related]
3. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
[TBL] [Abstract][Full Text] [Related]
4. Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes.
Wu GW; Kobashigawa JA; Fishbein MC; Patel JK; Kittleson MM; Reed EF; Kiyosaki KK; Ardehali A
J Heart Lung Transplant; 2009 May; 28(5):417-22. PubMed ID: 19416767
[TBL] [Abstract][Full Text] [Related]
5. Deposition of C4d and C3d in cardiac transplants: a factor in the development of coronary artery vasculopathy.
Moseley EL; Atkinson C; Sharples LD; Wallwork J; Goddard MJ
J Heart Lung Transplant; 2010 Apr; 29(4):417-23. PubMed ID: 20188594
[TBL] [Abstract][Full Text] [Related]
6. Peritubular capillary C4d deposition and renal outcome in post-transplant IgA nephropathy.
Choi J; Cho YM; Yang WS; Park TJ; Chang JW; Park SK
Clin Transplant; 2007; 21(2):159-65. PubMed ID: 17425739
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemistry staining of C4d to diagnose antibody-mediated rejection in cardiac transplantation.
Fedson SE; Daniel SS; Husain AN
J Heart Lung Transplant; 2008 Apr; 27(4):372-9. PubMed ID: 18374872
[TBL] [Abstract][Full Text] [Related]
8. The role of C4d immunostaining in the evaluation of the causes of renal allograft dysfunction.
Ranjan P; Nada R; Jha V; Sakhuja V; Joshi K
Nephrol Dial Transplant; 2008 May; 23(5):1735-41. PubMed ID: 18065805
[TBL] [Abstract][Full Text] [Related]
9. The significance of C4d staining with minimal histologic abnormalities.
Haas M
Curr Opin Organ Transplant; 2010 Feb; 15(1):21-7. PubMed ID: 19907328
[TBL] [Abstract][Full Text] [Related]
10. Measurement of human erythrocyte C4d to erythrocyte complement receptor 1 ratio in cardiac transplant recipients with acute symptomatic allograft failure.
Lee KC; Chang CY; Chuang YC; Sue SH; Chu TW; Chen RJ; Chen SH; Wei J; Chen CH
Transplant Proc; 2008 Oct; 40(8):2638-42. PubMed ID: 18929826
[TBL] [Abstract][Full Text] [Related]
11. C4d deposition in cardiac allografts correlates with alloantibody.
Smith RN; Brousaides N; Grazette L; Saidman S; Semigran M; Disalvo T; Madsen J; Dec GW; Perez-Atayde AR; Collins AB
J Heart Lung Transplant; 2005 Sep; 24(9):1202-10. PubMed ID: 16143234
[TBL] [Abstract][Full Text] [Related]
12. C4D deposition and positive posttransplant crossmatch are not necessarily markers of antibody-mediated rejection in renal allograft recipients.
Banasik M; Boratyńska M; Nowakowska B; Haloń A; Kościelska-Kasprzak K; Drulis-Fajdasz D; Patrzałek D; Weyde W; Klinger M
Transplant Proc; 2007 Nov; 39(9):2718-20. PubMed ID: 18021967
[TBL] [Abstract][Full Text] [Related]
13. Glomerular monocytes predict worse outcomes after acute renal allograft rejection independent of C4d status.
Tinckam KJ; Djurdjev O; Magil AB
Kidney Int; 2005 Oct; 68(4):1866-74. PubMed ID: 16164665
[TBL] [Abstract][Full Text] [Related]
14. Characterization of c4d immunostaining utilizing paraffin-embedded tissue of nonpresensitized pediatric heart transplant patients.
Galambos C; Feingold B; Webber SA
Pediatr Dev Pathol; 2008; 11(3):181-4. PubMed ID: 17990923
[TBL] [Abstract][Full Text] [Related]
15. The fate of C4d positive kidney allografts lacking histological signs of acute rejection.
Dickenmann M; Steiger J; Descoeudres B; Mihatsch M; Nickeleit V
Clin Nephrol; 2006 Mar; 65(3):173-9. PubMed ID: 16550748
[TBL] [Abstract][Full Text] [Related]
16. Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation.
Haga H; Egawa H; Fujimoto Y; Ueda M; Miyagawa-Hayashino A; Sakurai T; Okuno T; Koyanagi I; Takada Y; Manabe T
Liver Transpl; 2006 Mar; 12(3):457-64. PubMed ID: 16498648
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of C4d deposition in stable renal allografts in the early post-transplantation period.
Yoon HE; Kim SH; Kim JY; Oh EJ; Park SC; Choi BS; Choi YJ; Moon IS; Kim YS; Yang CW
Clin Transplant; 2009; 23(6):812-8. PubMed ID: 19191803
[TBL] [Abstract][Full Text] [Related]
18. C4d deposition in allograft renal biopsies is an independent risk factor for graft failure.
Wang R; Wang H; Chen J; Wu J; Wang Y; Huang H; He Q
Nephrology (Carlton); 2009 Aug; 14(5):527-32. PubMed ID: 19674321
[TBL] [Abstract][Full Text] [Related]
19. Complement fragment C4d and C3d deposition in pediatric heart recipients with a positive crossmatch.
Holt DB; Liapis H; Mohanakumar T; Phelan DR; Gandi SK; Huddleston CB; Canter CE
J Heart Lung Transplant; 2008 Oct; 27(10):1073-8. PubMed ID: 18926396
[TBL] [Abstract][Full Text] [Related]
20. C3d and C4d deposition early after lung transplantation.
Westall GP; Snell GI; McLean C; Kotsimbos T; Williams T; Magro C
J Heart Lung Transplant; 2008 Jul; 27(7):722-8. PubMed ID: 18582800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
